| Pronunciation |
 (sul
fa SYE
teen) |
 |
| U.S. Brand Names |
| Renoquid® |
|
| Generic Available |
|
No |
|
| Pharmacological Index |
|
Antibiotic, Sulfonamide Derivative |
|
| Use |
|
Treatment of urinary tract infections |
|
| Pregnancy Risk Factor |
|
B (D at term) |
|
| Contraindications |
|
Severe renal or hepatic impairment; porphyria; hypersensitivity to sulfacytine; children <14 years of age |
|
| Adverse Reactions |
|
>10%: Central nervous system: Fever, dizziness, headache Dermatologic: Itching, skin rash, photosensitivity Gastrointestinal: Anorexia, nausea, vomiting, diarrhea 1% to 10%: Dermatologic: Lyell's syndrome, Stevens-Johnson syndrome Hematologic: Granulocytopenia, leukopenia, thrombocytopenia, aplastic anemia, hemolytic anemia Hepatic: Hepatitis |
|
| Usual Dosage |
|
Adults: Oral: Initial: 500 mg, then 250 mg every 4 hours for 10 days |
|
| Dietary Considerations |
|
Should be administered 1 hour before or 2 hours after a meal on an empty stomach |
|
| Mental Health: Effects on Mental Status |
|
Dizziness is common |
|
| Mental Health: Effects on Psychiatric Treatment |
|
Photosensitivity is common; use caution with concurrent psychotropics; may cause granulocytopenia; caution with clozapine and carbamazepine |
|
| Dental Health: Local Anesthetic/Vasoconstrictor Precautions |
|
No information available to require special precautions |
|
| Dental Health: Effects on Dental Treatment |
|
No effects or complications reported |
|
| Dosage Forms |
|
Tablet: 250 mg |
|
|
|
Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved
